
MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

